Aptinyx Highlights Key Goals and Anticipated Development Milestones for 2022 by Seini Moimoi | Jan 6, 2022 | Portfolio News
Eargo Launches Eargo 6 with Sound Adjust for Effortless Hearing by Seini Moimoi | Jan 5, 2022 | Portfolio News
Avenge Bio Announces Closing of $45 Million Series A Financing by Seini Moimoi | Jan 5, 2022 | Portfolio News
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors by Seini Moimoi | Dec 23, 2021 | Portfolio News
Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics by Seini Moimoi | Dec 21, 2021 | Portfolio News
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-MUC1C-ALLO1, a Fully Allogeneic CAR-T Targeting Multiple Solid Tumors by Seini Moimoi | Dec 20, 2021 | Portfolio News
Checkmate Pharmaceuticals Strengthens Board of Directors with Appointment of Joy Yan, M.D., Ph.D. by Seini Moimoi | Dec 20, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Multi-Indication Trial Using Vidutolimod by Seini Moimoi | Dec 20, 2021 | Portfolio News
Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients by Seini Moimoi | Dec 17, 2021 | Portfolio News
Poseida Therapeutics Provides Update on BCMA-Targeted CAR-T Clinical Trials at the 2021 American Society of Hematology (ASH) Annual Meeting by Seini Moimoi | Dec 13, 2021 | Portfolio News
